Loading...
Pre-filled Intra-articular Syringe Hymovis Hyadd4 Hexadecillamide Hyaluronic Acid 24mg/3ml 2 Pieces of 3ml Not Sterilized A Eto Hymovis
6% off
€374,40
€400,00
Unit price
/
Unavailable
Tax included, shipping and discounts calculated at checkout.
HYMOVIS | SKU:
989259015
Notify me when it's back in stock!
Write us your email, you will be notified when this product becomes available again!
Pre-filled Intra-articular Syringe Hymovis Hyadd4 Hexadecillamide Hyaluronic Acid 24mg/3ml 2 Pieces of 3ml Not Sterilized A Eto Hymovis is backordered and will ship as soon as it is back in stock.
Shipping Costs and Times
Shipping Costs and Times
- Order fulfillment within 24 hours and delivery within the following 48/72 hours.
- Shipping cost: always free for orders over €49.90, otherwise it costs €4.99.
Payments
Payments
Payment information is processed securely. We do not store credit card information or have access to your credit card information.
Returns and Refunds
Returns and Refunds
You can return and receive a refund for the item within 30 days. See full policy here.
0.5 kg
Pre-filled Intra-articular Syringe Hymovis Hyadd4 Hexadecillamide H...
€374,40
€400,00
Unit price
/
Unavailable
Do you need help?
Our customer service is here to help you!
- Contact us by phone, email or WhatsApp, from Monday to Friday, from 9:00 to 20:00 .
- For common questions, such as tracking your order or checking its fulfillment status, you can count on our artificial intelligence , available 24/7 .
We are always at your side to offer you fast and effective support!
Description
Description
PRE-FILLED INTRA-ARTICULAR SYRINGE HYMOVIS HYADD4 HEXADECILLAMIDE HYALURONIC ACID 24MG/3ML 2 PIECES OF 3ML NOT STERILIZED WITH ETO HYMOVIS
HYMOVIS
Description
Sterile hydrogel made with Hyadd4 (highly purified natural sodium hyaluronate hexadecylamide obtained from bacterial fermentation) in a buffered isotonic solution. Thanks to the high viscosity and elasticity provided by sodium hyaluronate hexadecylamide, HYMOVIS improves the lubricating and shock-absorbing properties of synovial fluid, protecting cartilage and soft tissue from mechanical injury. These properties, combined with its prolonged permanence in the joints, allow HYMOVIS to relieve pain and improve joint function for up to six months in mild to moderate osteoarthritis of the hip and knee.
Indicated for the treatment of patients with mild to moderate osteoarthritis of the knee and hip. The device is indicated for the treatment of osteoarthritis of any nature.
HYMOVIS is administered exclusively by intra-articular injection.
The product must be administered exclusively by specialized medical personnel (e.g. orthopedic surgeon, rheumatologist, physiatrist, radiologist, sports doctor, etc.).
Remove any joint effusion, if present, before administration. Inject intra-articularly only. Intra-articular injection must be performed according to the standard technique, with precise anatomical localization. In the hip, ultrasound or radioscopic guidance is recommended. Strictly follow all aseptic administration guidelines.
Given its viscosity, inject HYMOVIS slowly into the joint using an appropriate sterile needle (18 or 20 G).
Treatment consists of a single injection. No clinical data are available with more than one HYMOVIS injection.
Components
Main component: Hyadd4 (sodium hyaluronate hexadecylamide), 32 mg/4 ml.
Other ingredients: sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.
Warnings
If there is venous or lymphatic stasis in the affected limb, HYMOVIS must not be injected into the joint.
Do not administer to patients with known individual hypersensitivity to the components of the product or in case of infections or skin diseases in the injection area.
Treatment should be avoided if the joint shows signs of acute inflammation.
The safety and efficacy of using HYMOVIS with other intra-articular treatments have not been established.
For the first 48 hours after the injection, the patient can perform all routine daily activities, but it is recommended not to overload the treated joint.
The syringe is for single use only; inject the contents into one joint only. The assembled syringe must be discarded immediately after use, regardless of whether the hydrogel has been completely administered.
If the product is reprocessed and/or reused, Fidia Farmaceutici cannot guarantee its performance, functionality, material structure, cleanliness, or sterility. Reuse may lead to illness, infection, and/or serious harm to the patient or user.
Do not use HYMOVIS after the expiration date printed on the carton. The expiration date refers to the product when stored properly in its original packaging.
Do not use HYMOVIS if the package is open or damaged.
Keep out of reach of children.
Conservation
Store in the original packaging between 2°C and 25°C. Do not freeze.
Format
Case containing 1 pre-filled luer lock syringe.
Cod. 10001310
Sterile hydrogel made with Hyadd4 (highly purified natural sodium hyaluronate hexadecylamide obtained from bacterial fermentation) in a buffered isotonic solution. Thanks to the high viscosity and elasticity provided by sodium hyaluronate hexadecylamide, HYMOVIS improves the lubricating and shock-absorbing properties of synovial fluid, protecting cartilage and soft tissue from mechanical injury. These properties, combined with its prolonged permanence in the joints, allow HYMOVIS to relieve pain and improve joint function for up to six months in mild to moderate osteoarthritis of the hip and knee.
Indicated for the treatment of patients with mild to moderate osteoarthritis of the knee and hip. The device is indicated for the treatment of osteoarthritis of any nature.
HYMOVIS is administered exclusively by intra-articular injection.
The product must be administered exclusively by specialized medical personnel (e.g. orthopedic surgeon, rheumatologist, physiatrist, radiologist, sports doctor, etc.).
Remove any joint effusion, if present, before administration. Inject intra-articularly only. Intra-articular injection must be performed according to the standard technique, with precise anatomical localization. In the hip, ultrasound or radioscopic guidance is recommended. Strictly follow all aseptic administration guidelines.
Given its viscosity, inject HYMOVIS slowly into the joint using an appropriate sterile needle (18 or 20 G).
Treatment consists of a single injection. No clinical data are available with more than one HYMOVIS injection.
Components
Main component: Hyadd4 (sodium hyaluronate hexadecylamide), 32 mg/4 ml.
Other ingredients: sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.
Warnings
If there is venous or lymphatic stasis in the affected limb, HYMOVIS must not be injected into the joint.
Do not administer to patients with known individual hypersensitivity to the components of the product or in case of infections or skin diseases in the injection area.
Treatment should be avoided if the joint shows signs of acute inflammation.
The safety and efficacy of using HYMOVIS with other intra-articular treatments have not been established.
For the first 48 hours after the injection, the patient can perform all routine daily activities, but it is recommended not to overload the treated joint.
The syringe is for single use only; inject the contents into one joint only. The assembled syringe must be discarded immediately after use, regardless of whether the hydrogel has been completely administered.
If the product is reprocessed and/or reused, Fidia Farmaceutici cannot guarantee its performance, functionality, material structure, cleanliness, or sterility. Reuse may lead to illness, infection, and/or serious harm to the patient or user.
Do not use HYMOVIS after the expiration date printed on the carton. The expiration date refers to the product when stored properly in its original packaging.
Do not use HYMOVIS if the package is open or damaged.
Keep out of reach of children.
Conservation
Store in the original packaging between 2°C and 25°C. Do not freeze.
Format
Case containing 1 pre-filled luer lock syringe.
Cod. 10001310